Optimization of Movement Patterns in Elite Volleyball Players

Prof. Dr. F. Staes37 enrolled

Overview

On the basis of clinical and movement analysis records players are informed on what parameters can be optimized in order to improve their performance and avoid injuries

Study Type

OBSERVATIONAL

Enrollment

Conditions

Optimisation of Performance and Avoidance of Injury

Interventions

advise for exercices given by team staffOTHER

To respond to questions asked: it is not the investigator who decides on the intervention, but the daily team staff (e.g. trainer, coach, PT,.....). So no predetermined intervention is provided

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Members of national volleyball team signing informed consent Exclusion Criteria: No specific exclusion criteria

Locations (1)

KU Leuven/UZLeuven

Leuven, Vlaams-Brabant, Belgium

Outcomes

Primary Outcomes

2D and 3D joint angles of different movements together with kinetics

kinematics and kinetics with regard to gait, running, jumping and arm movements. This means for example joint angles (measured by 3D motion analyses data, 2D measurement data) and kinetics (joint moments, pressure plate measurements) Time frames: these data will recorded by one measurement session. For information of clinicaltrials.gov (also other outcome measures): at this point it really is an observational study. It is a kind of "service project" for an elite athletes team. Advice is provided, but not as is meant within a real clinical trial. It might evolve to such a project, but at this state it is not the case.

Time frame: 1 day

Secondary Outcomes

muscle strength

isokinetic measurements (expressed in Nm)

Time frame: 1 day

muscle strength

isokinetic measurements (ratio agonist/antagonist as for example ratio between knee flexors/extensors) Time frames: these data will be recorded during one measurement session. This is during same session as for primary outcome measure.

Time frame: 1 day

joint stability

nominal scale (good, poor)

Time frame: 1 day

joint control

nominal scale (good, poor)

Time frame: 1 day

prevalence injury past

interview (frequency/percentage of occurrence)

Time frame: 1 day

prevalence injury present

interview (yes/no)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.